QL Block for Postoperative Pain in Fibroid Surgery
Trial Summary
What is the purpose of this trial?
This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you use chronic opioids, you may not be eligible to participate.
What data supports the effectiveness of the treatment QL Block for postoperative pain in fibroid surgery?
Is the quadratus lumborum block safe for humans?
The quadratus lumborum (QL) block has been used safely for managing pain after various surgeries, including abdominal, gynecological, and orthopedic procedures. It is generally considered safe, with studies showing reduced pain and opioid use, but more research is needed to confirm the best techniques.12678
How does the QL block treatment differ from other treatments for postoperative pain in fibroid surgery?
The QL block treatment is unique because it uses an ultrasound-guided technique to deliver local anesthesia to a specific area in the lower back, providing targeted pain relief after surgery. This method can reduce the need for opioids and improve patient satisfaction compared to traditional pain management options.12468
Research Team
Joseph Findley, MD
Principal Investigator
University Hospitals
Eligibility Criteria
This trial is for individuals needing surgery to remove uterine fibroids who can follow the study's procedures and are available throughout the study. They must understand and sign a consent form. It excludes those with anxiety, depression, blood clotting issues, chronic pain or opioid use, non-English speakers, and those with a BMI over 38.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a myomectomy procedure with or without a QL block for postoperative pain management
Follow-up
Participants are monitored for pain levels and satisfaction with pain management up to 48 hours after discharge
Treatment Details
Interventions
- QL Block (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Joseph Findley MD
Lead Sponsor